Haapasalo H - Search Results

1

Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.

Vihola A, Bachinski LL, Sirito M, Olufemi SE, Hajibashi S, Baggerly KA, Raheem O, Haapasalo H, Suominen T, Holmlund-Hampf J, Paetau A, Cardani R, Meola G, Kalimo H, Edström L, Krahe R, Udd B. Vihola A, et al. Among authors: haapasalo h. Acta Neuropathol. 2010 Apr;119(4):465-79. doi: 10.1007/s00401-010-0637-6. Epub 2010 Jan 12. Acta Neuropathol. 2010. PMID: 20066428 Free PMC article.

2

Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.

Haapasalo H, Isola J, Sallinen P, Kalimo H, Helin H, Rantala I. Haapasalo H, et al. Am J Pathol. 1993 May;142(5):1347-51. Am J Pathol. 1993. PMID: 7684193 Free PMC article.

3

[Hypothyroidism-associated alveolar hypoventilation and myopathy].

Saarelainen S, Jäntti V, Kalimo H, Haapasalo H. Saarelainen S, et al. Among authors: haapasalo h. Duodecim. 1993;109(9):759-63. Duodecim. 1993. PMID: 8062755 Finnish. No abstract available.

4

Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.

Kirla R, Salminen E, Huhtala S, Nuutinen J, Talve L, Haapasalo H, Kalimo H. Kirla R, et al. Among authors: haapasalo h. J Neurooncol. 2000;46(1):71-80. doi: 10.1023/a:1006473320474. J Neurooncol. 2000. PMID: 10896207

5

Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.

Kirla RM, Haapasalo HK, Kalimo H, Salminen EK. Kirla RM, et al. Among authors: haapasalo hk. Cancer. 2003 Feb 1;97(3):644-8. doi: 10.1002/cncr.11079. Cancer. 2003. PMID: 12548606 Free article.

6

Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2.

Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, Paetau A, Mancinelli E, Rouche A, Hogrel JY, Laforêt P, Maisonobe T, Pellissier JF, Krahe R, Eymard B, Udd B. Vihola A, et al. Among authors: haapasalo h. Neurology. 2003 Jun 10;60(11):1854-7. doi: 10.1212/01.wnl.0000065898.61358.09. Neurology. 2003. PMID: 12796551 Free article.

7

New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2).

Sallinen R, Vihola A, Bachinski LL, Huoponen K, Haapasalo H, Hackman P, Zhang S, Sirito M, Kalimo H, Meola G, Horelli-Kuitunen N, Wessman M, Krahe R, Udd B. Sallinen R, et al. Among authors: haapasalo h. Neuromuscul Disord. 2004 Apr;14(4):274-83. doi: 10.1016/j.nmd.2004.01.002. Neuromuscul Disord. 2004. PMID: 15019706

8

Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.

Guo D, Nilsson J, Haapasalo H, Raheem O, Bergenheim T, Hedman H, Henriksson R. Guo D, et al. Among authors: haapasalo h. Acta Neuropathol. 2006 Mar;111(3):238-46. doi: 10.1007/s00401-006-0032-5. Epub 2006 Mar 11. Acta Neuropathol. 2006. PMID: 16532360

9

Molecular genetic analysis of the REST/NRSF gene in nervous system tumors.

Blom T, Tynninen O, Puputti M, Halonen M, Paetau A, Haapasalo H, Tanner M, Nupponen NN. Blom T, et al. Among authors: haapasalo h. Acta Neuropathol. 2006 Oct;112(4):483-90. doi: 10.1007/s00401-006-0102-8. Epub 2006 Jul 6. Acta Neuropathol. 2006. PMID: 16823502

10

Hartia-lantiodystrofioiden molekyyligenetiikka Suomessa.

Raheem O, Suominen T, Hackman P, Vihola A, Auranen M, Kalimo H, Mahjneh I, Kärppä M, Haapasalo H, Udd B. Raheem O, et al. Among authors: haapasalo h. Duodecim. 2006;122(17):2130-6. Duodecim. 2006. PMID: 17115630 Finnish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page